AVENUE THERAPEUTICS INC - COM NEW (ATXI)

CUSIP: 05360L205

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM NEW
Total 13F shares
1,040,837
Share change
-1,330,941
Total reported value
$503,004
Price per share
$0.48
Number of holders
14
Value change
-$1,270,728
Number of buys
7
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 05360L205?
CUSIP 05360L205 identifies ATXI - AVENUE THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVENUE THERAPEUTICS INC - COM NEW (ATXI) as of Q1 2022

As of 31 Mar 2022, AVENUE THERAPEUTICS INC - COM NEW (ATXI) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,040,837 shares. The largest 10 holders included VANGUARD GROUP INC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, National Asset Management, Inc., Virtu Financial LLC, BlackRock Inc., TWO SIGMA SECURITIES, LLC, WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), and UBS Group AG. This page lists 14 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.